pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 23·1 min read
save

Amneal to buy a biosimilar company; Samsung Bio workers protest

Plus, news about Avonik, a supply chain transparency bill and Nucleus RadioPharma: 💰 Amneal Pharmaceuticals to acquire biosimilar maker for $375M upfront: The generics and specialty drugmaker is set to buy ...

Apr 23, 2026·read at Endpoints ↗

April 23, 2026 10:00 AM EDTUpdated 10:36 AM Manufacturing Am­neal to buy a biosim­i­lar com­pa­ny; Sam­sung Bio work­ers protest Anna Brown News Reporter Plus, news about Avonik, a sup­ply chain trans­paren­cy bill and Nu­cle­us Ra­dio­Phar­ma: 💰 Am­neal Phar­ma­ceu­ti­cals to ac­quire biosim­i­lar mak­er for $375M up­front: The gener­ics and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
83 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Biosimilar4

related stories

  • 1d agoAstraZeneca scores in lung cancer; Sandoz inks a China dealBioPharma Dive
  • 1d agoSandoz inks $322M Henlius deal for rights to as many as 10 biosimilarsBioSpace
  • 2d agoSTAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and moreSTAT
  • Aug 5Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPOFierce Biotech
  • Aug 3Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacityBioSpace